|
| |
| | |
| | |
| |
| | |
| | | |
| | Page 235, line 2 [Clause 257], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | | |
| | Page 235, line 4 [Clause 257], leave out ‘or 12’. |
|
| | |
| | | |
| | Page 235, line 11 [Clause 257], leave out subsection (7). |
|
| | |
| | | |
| | Page 235, line 17 [Clause 258], leave out ‘, analysis and publication or other |
|
| | dissemination’ and insert ‘and analysis’. |
|
| | |
| | | |
| | Page 235, line 24 [Clause 258], leave out subsection (3). |
|
| | |
| | | |
| | Page 235, line 43 [Clause 258], leave out ‘the United Kingdom’ and insert |
|
| | |
| | |
| | |
| | | |
| | Page 238, line 19 [Clause 262], at end insert ‘which is collected pursuant to the |
|
| | |
| | |
| | | |
| | Page 238, line 20 [Clause 262], leave out subsections (4) to (7). |
|
| | |
| | | |
| | Page 238, line 42 [Clause 262], leave out from ‘258’ to end of line 44 and insert ‘, |
|
| | |
| | | (a) | must comply with the requirements (if any) specified in the direction or |
|
| | | mandatory request as to the form, manner and timing of publication of the |
|
| | | |
| | | (b) | may publish the information in such other form and such other manner, |
|
| | | and at such other times, as it considers appropriate.’. |
|
| | |
| | | |
| | Page 238, line 47 [Clause 262], leave out from ‘Centre’ to end of line 48 and insert |
|
| | |
|
| |
| | |
| | |
| |
| | | (a) | may act in accordance with such provision (if any) as may be included in |
|
| | | the request as to the form, manner and timing of publication of the |
|
| | | |
| | | (b) | may publish the information in such other form and such other manner, |
|
| | | and at such other times, as it considers appropriate.’. |
|
| | |
| | |
| | | |
| | Page 239, line 1 [Clause 262], leave out ‘intervals for’ and insert ‘timings of’. |
|
| | |
| | | |
| | Page 239, line 7 [Clause 262], leave out ‘section’ and insert ‘Chapter’. |
|
| | |
| | |
| | | |
| | Page 243, line 28 [Clause 274], leave out paragraph (c) and insert— |
|
| | | ‘(c) | a Northern Ireland Minister;’. |
|
| | |
| | | |
| | Page 243, line 35 [Clause 274], at end insert— |
|
| | | ‘“Northern Ireland Minister” includes the First Minister, the deputy First |
|
| | | Minister and a Northern Ireland Department;’. |
|
| | |
| | | |
| | Page 243, line 40 [Clause 274], at end insert— |
|
| | | ‘“relevant person” has the meaning given by section 262.’. |
|
| | |
| | |
| | | |
| | Page 247, line 14 [Clause 283], leave out ‘commissioning consortia’ and insert |
|
| | ‘clinical commissioning groups’. |
|
| | |
| | | |
| | Page 247, line 32 [Clause 284], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
|
| |
| | |
| | |
| |
| | |
| | | |
| | Page 248, line 41 [Clause 286], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | |
| | | |
| | Page 249, line 26 [Clause 286], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | |
| | | |
| | Page 254, line 37 [Clause 297], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | | |
| | Page 254, line 42 [Clause 297], leave out ‘consortium’ and insert ‘clinical |
|
| | |
| | |
| | |
| | |
| | |
| | | |
| | 
| Page 256, line 31, leave out Clause 299. |
|
| | |
| | |
| | | |
| | Page 257, line 14 [Clause 299], leave out ‘section 300’ and insert ‘sections 300 and |
|
| | [Subsequent property transfer schemes]’. |
|
| | |
| | | |
| | Page 257, line 18 [Clause 299], at end insert ‘or the Board’. |
|
| | |
| | |
| | |
| | | |
| | | Page 257, line 29, leave out Clause 300. |
|
|
| |
| | |
| | |
| |
| | |
| | | |
| | Page 257, line 39 [Clause 300], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | |
| | | |
| | Page 259, line 39 [Clause 302], leave out from ‘section’ to end of line 40 and insert |
|
| | ‘[Duration of transitional period] (extension of transitional period during which licence |
|
| | conditions may be imposed on NHS foundation trusts)’. |
|
| | |
| | |
| | | |
| | Page 260, line 11 [Clause 302], leave out subsection (6) and insert— |
|
| | | ‘(6) | An order by the Privy Council under this Act that includes provision which |
|
| | | would, if included in an Act of the Scottish Parliament, fall within the legislative |
|
| | | competence of that Parliament is subject to the negative procedure in that |
|
| | | Parliament (in addition to the statutory instrument containing the order being |
|
| | | subject to annulment under subsection (3)). |
|
| | | (6A) | Sections 28 and 31 of the Interpretation and Legislative Reform (Scotland) Act |
|
| | | 2010 (negative procedure etc.) apply in relation to an order of the description |
|
| | | given in subsection (6) as they apply in relation to devolved subordinate |
|
| | | legislation (within the meaning of Part 2 of that Act) that is subject to the negative |
|
| | | procedure, but as if references to a Scottish statutory instrument were references |
|
| | | to a statutory instrument. |
|
| | | (6B) | Section 32 of that Act (laying) shall apply in relation to the laying of a statutory |
|
| | | instrument containing an order of the description given in subsection (6) before |
|
| | | the Scottish Parliament as it applies in relation to the laying of a Scottish statutory |
|
| | | instrument (within the meaning of Part 2 of that Act) before that Parliament.’. |
|
| | |
| | | |
| | Page 260, line 37 [Clause 302], leave out ‘or transitional’ and insert ‘, transitional |
|
| | |
| | |
| | | |
| | Page 260, line 42 [Clause 302], at end insert— |
|
| | | ‘(8A) | If a draft of a statutory instrument containing an order under section [Duration of |
|
| | | transitional period] would, but for this subsection, be treated for the purposes of |
|
| | | the Standing Orders of either House of Parliament as a hybrid instrument, it is to |
|
| | | proceed in that House as if it were not a hybrid instrument.’. |
|
| | |
| | | |
| | Page 260, line 45 [Clause 302], leave out ‘must be given by regulations or’ and |
|
| | |
|
| |
| | |
| | |
| |
| | | (a) | must, in the case of a direction under any of the following provisions, be |
|
| | | given by regulations or an instrument in writing— |
|
| | | (i) | section 66(2) (direction to Monitor to perform functions); |
|
| | | (ii) | section 237(1) (direction to NICE to prepare quality standards); |
|
| | | (iii) | section 248(1) (direction to NICE to perform functions); |
|
| | | (iv) | section 252(8) (direction to Board to be transitional |
|
| | | commissioner in relation to pre-commencement statements of |
|
| | | |
| | | (v) | section 257(1) (direction to Information Centre to establish |
|
| | | |
| | | (vi) | section 258(6) or (7) (direction to Information Centre to comply, |
|
| | | or not to comply, with request to establish information systems); |
|
| | | (vii) | section 262(2)(d) (direction to Information Centre that |
|
| | | information of specified description is not subject to duty to |
|
| | | |
| | | (viii) | section 271(1) (direction to Information Centre to perform |
|
| | | |
| | | (ix) | paragraph 4 of Schedule 6 (direction to Board to exercise |
|
| | | functions of Secretary of State relating to Primary Care Trusts), |
|
| | | |
| | | (b) | must, in the case of any other direction, be given by’. |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | | |
| | Page 261, line 19 [Clause 304], at end insert— |
|
| | | ‘(1A) | Section 29 comes into force in accordance with sections 29(3) and (4).’. |
|
| | |
| | | |
| | Page 261, line 29 [Clause 304], leave out from beginning to ‘may’ in line 30 and |
|
| | insert ‘Transitory provision in an order under subsection (2) or (4)’. |
|
| | |
| | | |
| | Page 261, line 43 [Clause 305], at end insert— |
|
| | | ‘( ) | section 42 insofar as it inserts section 252A(7A) of the National Health |
|
| | | |
| | |
| | |
| | | |
| | Page 262, line 16 [Clause 305], leave out subsection (4). |
|
|
| |
| | |
| | |
| |
| | |
| | | |
| | Page 262, line 18 [Clause 305], leave out ‘The following provisions’ and insert |
|
| | ‘Sections 131 to 136 (health special administration)’. |
|
| | |
| | | |
| | Page 262, line 19 [Clause 305], leave out paragraphs (a) and (b). |
|
| | |
| | |
| | | |
| | Page 267, line 33 [Schedule 1], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | |
| | | |
| | Page 268, line 13 [Schedule 1], leave out ‘commissioning consortia’ and insert |
|
| | ‘clinical commissioning groups’. |
|
| | |
| | |
| | | |
| | Page 269, line 4 [Schedule 2], leave out ‘Commissioning consortia’ and insert |
|
| | ‘Clinical commissioning groups’. |
|
| | |
| | | |
| | Page 269, line 6 [Schedule 2], leave out ‘commissioning consortia’ and insert |
|
| | ‘clinical commissioning groups’. |
|
| | |
| | | |
| | Page 269, line 8 [Schedule 2], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | | |
| | Page 269, line 10 [Schedule 2], leave out ‘consortium’ and insert ‘clinical |
|
| | |
| | |
| | | |
| | Page 269, line 11 [Schedule 2], leave out ‘consortium’ and insert ‘group’. |
|
|
| |
| | |
| | |
| |
| | |
| | | |
| | Page 269, line 12 [Schedule 2], leave out ‘consortium’ and insert ‘group’. |
|
| | |
| | | |
| | Page 269, line 13 [Schedule 2], leave out ‘consortium’ and insert ‘group’. |
|
| | |
| | | |
| | Page 269, line 16 [Schedule 2], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | | |
| | Page 269, line 21 [Schedule 2], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | | |
| | Page 269, line 23 [Schedule 2], leave out ‘commissioning consortium’ and insert |
|
| | |
| | |
| | | |
| | Page 269, line 26 [Schedule 2], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | | |
| | Page 269, line 29 [Schedule 2], leave out ‘consortium’ and insert ‘group’. |
|
| | |
| | | |
| | | Page 269, line 29 [Schedule 2], at end insert— |
|
| | | ‘(4) | Nothing in paragraph (3) shall authorise the inclusion of any provision for any of |
|
| | | such functions to be exercised by— |
|
| | | (a) | any of the clinical commissioning group’s members who hold or benefit |
|
| | | from contracts to provide primary medical services under section 83(2); |
|
| | | |
| | | (b) | individuals who have been employees of such members; or |
|
| | | (c) | by a governing body, committee or sub-committee which consists |
|
| | | entirely or mainly of such members.’. |
|
| | |
| | | |
| | Page 269, line 31 [Schedule 2], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
| | |
| | | |
| | Page 269, line 34 [Schedule 2], leave out ‘commissioning consortium’ and insert |
|
| | ‘clinical commissioning group’. |
|
|
